Amgen(AMGN) ZACKS·2025-01-28 16:05Core Viewpoint - Amgen is expected to report a year-over-year increase in earnings and revenues for the quarter ended December 2024, with the actual results being a significant factor influencing its near-term stock price [1][2]. Earnings Expectations - The consensus estimate for Amgen's quarterly earnings is 8.84 billion, which is a 7.9% increase from the same quarter last year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 0.17%, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Amgen is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of 3.15% [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive Earnings ESP reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [8]. - Amgen currently holds a Zacks Rank of 3, indicating a likelihood of beating the consensus EPS estimate [11]. Historical Performance - In the last reported quarter, Amgen exceeded the expected earnings of 5.58, resulting in a surprise of 9.20% [12]. - Over the past four quarters, Amgen has consistently beaten consensus EPS estimates [13]. Conclusion - While Amgen is positioned as a strong candidate for an earnings beat, other factors should also be considered when evaluating the stock ahead of its earnings release [16].